PRKAG2 mutations presenting in infancy
- 11 August 2017
- journal article
- case report
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 40 (6) , 823-830
Abstract
PRKAG2 encodes the γ2 subunit of AMP-activated protein kinase (AMPK), which is an important regulator of cardiac metabolism. Mutations in PRKAG2 cause a cardiac syndrome comprising ventricular hypertrophy, pre-excitation, and progressive conduction-system disease, which is typically not diagnosed until adolescence or young adulthood. However, significant variability exists in the presentation and outcomes of patients with PRKAG2 mutations, with presentation in infancy being underrecognized. The diagnosis of PRKAG2 can be challenging in infants, and we describe our experience with three patients who were initially suspected to have Pompe disease yet ultimately diagnosed with mutations in PRKAG2. A disease-causing PRKAG2 mutation was identified in each case, with a novel missense mutation described in one patient. We highlight the potential for patients with PRKAG2 mutations to mimic Pompe disease in infancy and the need for confirmatory testing when diagnosing Pompe disease.Keywords
This publication has 29 references indexed in Scilit:
- Effect of enzyme therapy and prognostic factors in 69 adults with Pompe disease: an open-label single-center studyOrphanet Journal of Rare Diseases, 2012
- Hypertrophic Cardiomyopathy in ChildhoodHeart Failure Clinics, 2010
- Antenatal diagnosis of pompe disease by fetal echocardiography: impact on outcome after early initiation of enzyme replacement therapyJournal of Inherited Metabolic Disease, 2010
- Modulating Phenotypic Expression of the PRKAG2 Cardiac SyndromeCirculation, 2008
- Pompe disease diagnosis and management guidelineGenetics in Medicine, 2006
- A new mutation in PRKAG2 gene causing hypertrophic cardiomyopathy with conduction system disease and muscular glycogenosisNeuromuscular Disorders, 2006
- Fatal Congenital Heart Glycogenosis Caused by a Recurrent Activating R531Q Mutation in the γ2-Subunit of AMP-Activated Protein Kinase (PRKAG2), Not by Phosphorylase Kinase DeficiencyThe American Journal of Human Genetics, 2005
- Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndromeJACC, 2005
- Mutations in the gamma2 subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesisHuman Molecular Genetics, 2001
- Familial Hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3.Journal of Clinical Investigation, 1995